Yuhan Corp. has secured regulatory approval in China for Lazcluze, its lung cancer drug licensed to Johnson & Johnson, ...

Amorepacific Holdings delivered a dramatic earnings rebound in the second quarter, reporting a 555 percent year-over-year ...

The Korea Medical Device Industry Association (KMDIA) announced on Friday that it has published the “2025 Medical Device ...

With the summer vacation season coinciding with a heatwave, indoor activities have increased, leading to a slight rise in ...

AstraZeneca Korea has partnered with a lesser-known Seoul startup to tackle one of the murkiest corners of breast cancer ...

Environmental, social, and governance (ESG) values have moved from corporate buzzword to business necessity in Korea’s ...

Korea’s medical device industry ranks seventh worldwide in terms of capabilities, and aims to achieve an even higher ranking ...

A woman in her 40s, known only by her family name of Park, was diagnosed with cystitis several times and took antibiotics.

EzDiatech, a company specializing in in vitro diagnostics, has developed a blood test for concussion called “VEUPLEX TBI ...

Hanok's Fabry disease treatment, Galafold (migalastat), will have its insurance coverage criteria expanded to include ...

LG H&H posted a steep decline in earnings for the second quarter of 2025, weighed down by sluggish consumer sentiment in ...

The government's mandatory submission of long-term treatment data for traffic accident patients has sparked fierce opposition ...